GRIFOLS S A/S Stock Price, News & Analysis (NASDAQ:GRFS)

$20.51
-0.05 (-0.24 %)
(As of 09/20/2019 04:00 PM ET)
Today's Range
$20.3050
Now: $20.51
$20.57
50-Day Range
$19.86
MA: $21.41
$22.78
52-Week Range
$17.42
Now: $20.51
$23.03
Volume2.22 million shs
Average Volume1.51 million shs
Market Capitalization$14.10 billion
P/E Ratio17.53
Dividend Yield1.28%
Beta1.11
Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GRFS
CUSIPN/A
Phone212-969-3335

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.30 billion
Cash Flow$1.5668 per share
Book Value$8.07 per share

Profitability

Net Income$704.63 million

Miscellaneous

Employees21,230
Market Cap$14.10 billion
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable

Receive GRFS News and Ratings via Email

Sign-up to receive the latest news and ratings for GRFS and its competitors with MarketBeat's FREE daily newsletter.


GRIFOLS S A/S (NASDAQ:GRFS) Frequently Asked Questions

What is GRIFOLS S A/S's stock symbol?

GRIFOLS S A/S trades on the NASDAQ under the ticker symbol "GRFS."

How often does GRIFOLS S A/S pay dividends? What is the dividend yield for GRIFOLS S A/S?

GRIFOLS S A/S declared a Semi-Annual dividend on Wednesday, May 29th. Stockholders of record on Monday, June 10th will be given a dividend of $0.14 per share on Tuesday, June 18th. The ex-dividend date is Friday, June 7th. View GRIFOLS S A/S's Dividend History.

When did GRIFOLS S A/S's stock split? How did GRIFOLS S A/S's stock split work?

GRIFOLS S A/S's stock split on Monday, January 4th 2016. The 2-1 split was announced on Thursday, December 3rd 2015. The newly issued shares were payable to shareholders after the market closes on Thursday, December 31st 2015. An investor that had 100 shares of GRIFOLS S A/S stock prior to the split would have 200 shares after the split.

How were GRIFOLS S A/S's earnings last quarter?

GRIFOLS S A/S (NASDAQ:GRFS) issued its earnings results on Wednesday, July, 31st. The biotechnology company reported $0.33 earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of $0.33. The biotechnology company had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.38 billion. GRIFOLS S A/S had a net margin of 11.82% and a return on equity of 14.88%. View GRIFOLS S A/S's Earnings History.

When is GRIFOLS S A/S's next earnings date?

GRIFOLS S A/S is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for GRIFOLS S A/S.

What price target have analysts set for GRFS?

5 brokerages have issued twelve-month price targets for GRIFOLS S A/S's stock. Their forecasts range from $19.00 to $22.50. On average, they expect GRIFOLS S A/S's stock price to reach $20.75 in the next year. This suggests a possible upside of 1.2% from the stock's current price. View Analyst Price Targets for GRIFOLS S A/S.

What is the consensus analysts' recommendation for GRIFOLS S A/S?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GRIFOLS S A/S in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for GRIFOLS S A/S.

Has GRIFOLS S A/S been receiving favorable news coverage?

Headlines about GRFS stock have been trending somewhat negative on Saturday, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. GRIFOLS S A/S earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned media coverage about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for GRIFOLS S A/S.

Are investors shorting GRIFOLS S A/S?

GRIFOLS S A/S saw a drop in short interest during the month of August. As of August 31st, there was short interest totalling 2,480,000 shares, a drop of 6.1% from the July 31st total of 2,640,000 shares. Based on an average trading volume of 1,500,000 shares, the short-interest ratio is presently 1.7 days. Approximately 1.0% of the shares of the stock are sold short. View GRIFOLS S A/S's Current Options Chain.

Who are some of GRIFOLS S A/S's key competitors?

What other stocks do shareholders of GRIFOLS S A/S own?

Who are GRIFOLS S A/S's key executives?

GRIFOLS S A/S's management team includes the folowing people:
  • Mr. Raimon Grifols Roura, Co-CEO & Exec. Director (Age 55)
  • Mr. Tomás Dagá Gelabert, Vice Sec. & External Director (Age 63)
  • Mr. Víctor Grífols Deu, Co-CEO & Exec. Director (Age 42)
  • Mr. Alfredo Arroyo Guerra, CFO & Corp. VP (Age 61)
  • Mrs. Eva Bastida Tubau, Corp. VP and Director of Scientific & Medical Affairs

Who are GRIFOLS S A/S's major shareholders?

GRIFOLS S A/S's stock is owned by many different of retail and institutional investors. Top institutional investors include AKO Capital LLP (1.83%), Pictet Asset Management Ltd. (1.00%), First Trust Advisors LP (0.74%), Farallon Capital Management LLC (0.45%), Bank of New York Mellon Corp (0.37%) and Price T Rowe Associates Inc. MD (0.30%).

Which major investors are selling GRIFOLS S A/S stock?

GRFS stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Bank of New York Mellon Corp, Bank of America Corp DE, Pictet Asset Management Ltd., CIBC Asset Management Inc, Van ECK Associates Corp, Renaissance Technologies LLC and BlackRock Inc..

Which major investors are buying GRIFOLS S A/S stock?

GRFS stock was bought by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Mackenzie Financial Corp, Morgan Stanley, AKO Capital LLP, Marshall Wace LLP, UBS Group AG, Marshall Wace North America L.P. and Citadel Advisors LLC.

How do I buy shares of GRIFOLS S A/S?

Shares of GRFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is GRIFOLS S A/S's stock price today?

One share of GRFS stock can currently be purchased for approximately $20.51.

How big of a company is GRIFOLS S A/S?

GRIFOLS S A/S has a market capitalization of $14.10 billion and generates $5.30 billion in revenue each year. The biotechnology company earns $704.63 million in net income (profit) each year or $1.17 on an earnings per share basis. GRIFOLS S A/S employs 21,230 workers across the globe.View Additional Information About GRIFOLS S A/S.

What is GRIFOLS S A/S's official website?

The official website for GRIFOLS S A/S is http://www.grifols.com/.

How can I contact GRIFOLS S A/S?

GRIFOLS S A/S's mailing address is 152-158 PARC DE NEGOCIS CAN SANT JOAN SANT CUGAT DEL VALL¿S, BARCELONA U3, 08174. The biotechnology company can be reached via phone at 212-969-3335 or via email at [email protected]


MarketBeat Community Rating for GRIFOLS S A/S (NASDAQ GRFS)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  264 (Vote Outperform)
Underperform Votes:  361 (Vote Underperform)
Total Votes:  625
MarketBeat's community ratings are surveys of what our community members think about GRIFOLS S A/S and other stocks. Vote "Outperform" if you believe GRFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GRFS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2019 by MarketBeat.com Staff

Featured Article: Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel